Twenty years of moving regulated materials the right way
Adapharma exists to remove the sourcing risk pharmaceutical manufacturers can't afford to carry — connecting qualified global suppliers to buyers who need documentation, not just delivery.
A sourcing partner, structured like a regulatory function
Adapharma was founded on a simple observation: pharmaceutical companies were spending as much time verifying their suppliers as they were sourcing from them. We built our company to close that gap — operating internally the way a quality assurance department would, with supplier audits, documentation control and traceability built into every transaction rather than added on afterward.
Today, Adapharma coordinates a qualified network of manufacturers across Asia, Europe, North America and Latin America, supplying Active Pharmaceutical Ingredients, excipients, injection-grade materials, laboratory equipment and manufacturing spare parts to clients who cannot afford supply disruption or documentation gaps.
- Founded2005
- HeadquartersMulti-Regional
- Manufacturing Partners180+
- Countries Served46+
- Product Categories6
Remove sourcing risk from regulated supply chains
We qualify, document and deliver pharmaceutical materials so our clients can focus on manufacturing, not vendor verification.
Become the reference standard for pharmaceutical sourcing
A global network where regulatory compliance, transparency and continuity of supply are the default, not the exception.
Precision, transparency, partnership
We qualify rigorously, document honestly, and build supplier and client relationships built to outlast a single order.
Qualify before we sell
Every supplier that joins the Adapharma network passes through a structured qualification process before a single product is listed: facility audit, GMP verification, dossier review and sample testing. We do not act as a marketplace connecting anonymous buyers and sellers — we take direct responsibility for the materials that move through our network.
This means fewer suppliers than a typical trading company, and a slower onboarding process. It also means our clients spend less time on supplier due diligence and more time on production.
Facility Audit
On-site or documented review of GMP status, equipment and quality systems.
Dossier Review
DMF, CEP and regional registration documents verified against target markets.
Sample Testing
Independent lab verification against COA specifications before approval.
Ongoing Surveillance
Re-audits, batch monitoring and documentation renewal on a fixed schedule.
Two decades of network building
Founded as a regional API trading company
Adapharma begins operations sourcing active ingredients for domestic generic manufacturers.
Expansion into excipients and injection-grade materials
Product range broadens in response to client demand for a single qualified sourcing partner.
Formal supplier qualification framework introduced
Structured audit and documentation process implemented across the entire supplier network.
Manufacturing equipment and laboratory instrumentation added
Adapharma extends sourcing capability beyond raw materials into capital equipment.
Network reaches 46+ countries
Regional warehousing and logistics partnerships established across four continents.
A network built region by region, audit by audit
Adapharma's manufacturing partnerships are established directly, not through intermediaries — giving clients traceability back to source on every material.